Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2025 02:19 ET | Source: Pharma Equity Group A/S

Pharma Equity Group A/S aftale med Danske Bank som liquidity provider ophører 1. januar 2026

Pharma Equity Group A/S aftale med Danske Bank som liquidity provider ophører 1. januar 2026 3. december 2025 Selskabsmeddelelse nr. 14 Pharma Equity Group A/S (”PEG”) meddeler, at selskabets...
December 03, 2025 02:19 ET | Source: Pharma Equity Group A/S

Pharma Equity Group A/S’ agreement with Danske Bank as liquidity provider will terminate on 1 January 2026

Pharma Equity Group A/S’ agreement with Danske Bank as liquidity provider will terminate on 1 January 2026 3 December 2025 Company Announcement no. 14 Pharma Equity Group A/S (“PEG”) announces...
December 01, 2025 07:10 ET | Source: Pharma Equity Group A/S

Bestyrelsens beslutning om udstedelse af konvertible lån

Bestyrelsens beslutning om udstedelse af konvertible lån 1. december 2025Meddelelse nr. 13 Bestyrelsen i Pharma Equity Group har truffet beslutning om udstedelse af konvertible obligationer i...
December 01, 2025 07:10 ET | Source: Pharma Equity Group A/S

The Board of Directors' resolution on the issuance of convertible loans

The Board of Directors' resolution on the issuance of convertible loans December 1, 2025Announcement no. 13 The Board of Directors of Pharma Equity Group has decided to issue convertible loans in...
November 26, 2025 10:40 ET | Source: Pharma Equity Group A/S

Korrigerende information til årsrapporten 2024 samt delårsrapporten for 1. halvår 2025 som følge af påbud fra Erhvervsstyrelsen

Korrigerende information til årsrapporten 2024 samt delårsrapporten for 1. halvår 2025 som følge af påbud fra Erhvervsstyrelsen København, 26. november 2025 Selskabsmeddelelse nr. 12 Pharma Equity...
November 26, 2025 10:40 ET | Source: Pharma Equity Group A/S

Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority

Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority Copenhagen, 26 November 2025 Company Announcement no....
October 01, 2025 03:24 ET | Source: Pharma Equity Group A/S

Bestyrelsens beslutning om udstedelse af konvertible lån

Bestyrelsens beslutning om udstedelse af konvertible lån 1. oktober 2025Meddelelse nr. 11 Bestyrelsen i Pharma Equity Group har truffet beslutning om udstedelse af konvertible lån i henhold...
October 01, 2025 03:24 ET | Source: Pharma Equity Group A/S

The Board of Directors' resolution on the issuance of convertible loans

The Board of Directors' resolution on the issuance of convertible loans October 1, 2025Announcement no. 11 The Board of Directors of Pharma Equity Group has decided to issue convertible...
September 02, 2025 04:04 ET | Source: Pharma Equity Group A/S

Korrektion: Pharma Equity Groups datterselskab, Reponex Pharmaceuticals A/S, har fået myndighedsgodkendelse til at igangsætte afgørende klinisk studie med RNX-011 til livstruende peritonitis

Pharma Equity Groups datterselskab, Reponex Pharmaceuticals A/S, har fået myndighedsgodkendelse til at igangsætte afgørende klinisk studie med RNX-011 til livstruende peritonitis Denne...
September 02, 2025 04:04 ET | Source: Pharma Equity Group A/S

Correction: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis

Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis This company...